Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin

Sip Dinkla, Bram van Cranenbroek, Wouter A. van der Heijden, Xuehui He, Rike Wallbrecher, Ingrid E. Dumitriu, André J. van der Ven, Giel J. C. G. M. Bosman, Hans J. P. M. Koenen, Irma Joosten

Blood (2016) 127 (16): 1976–1986.

https://doi.org/10.1182/blood-2015-04-640300

Published: 2016

Includes: Supplemental data

Journal Articles

Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells

Jorieke H. Peters, Hans J. P. M. Koenen, Esther Fasse, Henk J. Tijssen, Jan N. M. IJzermans, Patricia J. T. A. Groenen, Nicolaas P. M. Schaap, Jaap Kwekkeboom, Irma Joosten

Blood (2013) 122 (13): 2213–2223.

https://doi.org/10.1182/blood-2013-03-489443

Published: 2013

Includes: Supplemental data

Journal Articles

Human CD25 high Foxp3 pos regulatory T cells differentiate into IL-17–producing cells

Hans J. P. M. Koenen, Ruben L. Smeets, Paul M. Vink, Esther van Rijssen, Annemieke M. H. Boots, Irma Joosten

Blood (2008) 112 (6): 2340–2352.

https://doi.org/10.1182/blood-2008-01-133967

Published: 2008

Includes: Supplemental data

Journal Articles

The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4 + CD25 − T cells

Ellen Kreijveld, Hans J. P. M. Koenen, Luuk B. Hilbrands, Hans J. P. van Hooff, Irma Joosten

Blood (2006) 109 (1): 244–252.

https://doi.org/10.1182/blood-2006-05-021931

Published: 2006

Journal Articles

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27 + subset of human CD4 + CD25 + regulatory T cells

Jeroen J. A. Coenen, Hans J. P. M. Koenen, Esther van Rijssen, Luuk B. Hilbrands, Irma Joosten

Blood (2006) 107 (3): 1018–1023.

https://doi.org/10.1182/blood-2005-07-3032

Published: 2006

Journal Articles

Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness

Hans J. P. M. Koenen, Irma Joosten

Blood (2000) 95 (10): 3153–3161.

https://doi.org/10.1182/blood.V95.10.3153

Published: 2000

NARROW

Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin

Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells

Human CD25 high Foxp3 pos regulatory T cells differentiate into IL-17–producing cells

The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4 + CD25 − T cells

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27 + subset of human CD4 + CD25 + regulatory T cells

Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness

Email alerts

ASH Publications

American Society of Hematology

Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin

Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells

Human CD25 high Foxp3 pos regulatory T cells differentiate into IL-17–producing cells

The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4 + CD25 − T cells

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27 + subset of human CD4 + CD25 + regulatory T cells

Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only